Reaction
Endometrial Hypertrophy reporting signals
As of the last recalculation, Endometrial Hypertrophy appears in 399 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is RALOXIFENE HYDROCHLORIDE (PRR 48.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Raloxifene Hydrochloride | 13 | 48.0 | 48.0 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 13 | 29.7 | 29.7 |
| Medroxyprogesterone Acetate | 26 | 29.1 | 29.1 |
| Levonorgestrel | 33 | 9.2 | 9.2 |